Tag Archives: MBS

Pharmacist access to the MBS one step closer

The Pharmaceutical Society of Australia (PSA) has called on the Medicare Benefits Schedule (MBS) Review Taskforce to increase the role of pharmacists to address the healthcare needs of all Australians. The PSA’s recommendations, which stem from its two key reports, Medicine Safety: Take care and Pharmacists in 2023, made to …

Read More »

PSA: raise remuneration rates

PSA lodged two major submissions this week, both addressing pharmacist remuneration. In one submission, PSA National President Dr Chris Freeman wrote to the Medicare Benefits Schedule (MBS) Review Taskforce, to propose better use of existing MBS services by fully harnessing the knowledge, skills and accessibility of pharmacists. On behalf of …

Read More »

Add us to the MBS: PSA

The recommendation to add pharmacists to the list of eligible allied health professionals to access Medicare Benefits Schedule (MBS) items, for medication management services for patients with complex care requirements, is an important investment in the safe and effective use of medicines, the Pharmaceutical Society of Australia (PSA) said. The …

Read More »

Remote renal dialysis funded

People needing lifesaving renal dialysis in remote areas may benefit from the additional $34.8 million committed to fund end-stage kidney disease treatment. The four-year commitment is intended to help ensure patients – in particular, Aboriginal and Torres Strait Islanders (ATSIs) – receive the necessary critical care, when and where they …

Read More »

NPS Medicinewise gets certainty of funding

NPS MedicineWise has welcomed the budget’s four years of Commonwealth funding for the continuation of its work to improve quality use of medicines and medical tests. “Quality use of medicines and medical tests remains a cornerstone of quality healthcare and we’re pleased the Australian government has reaffirmed its ongoing commitment …

Read More »